Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia

Yusuke Seino; Shinji Ueno; Daisuke Yabe; Atsushi Suzuki

doi:10.1111/jdi.13135

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia

Yusuke Seino, Shinji Ueno, Daisuke Yabe, Atsushi Suzuki

Endocrinology & Metabolism

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1405-1407
Number of pages	3
Journal	Journal of Diabetes Investigation
Volume	10
Issue number	6
DOIs	https://doi.org/10.1111/jdi.13135
Publication status	Published - 01-11-2019

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1111/jdi.13135

Cite this

@article{0bf9808028b148a9b44b367c69f6fd43,

title = "Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia",

author = "Yusuke Seino and Shinji Ueno and Daisuke Yabe and Atsushi Suzuki",

note = "Funding Information: YS received a scholarship grant from Grants‐in‐Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd. Funding Information: YS received a scholarship grant from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd.",

year = "2019",

month = nov,

day = "1",

doi = "10.1111/jdi.13135",

language = "English",

volume = "10",

pages = "1405--1407",

journal = "Journal of Diabetes Investigation",

issn = "2040-1116",

publisher = "Blackwell Publishing Asia Pty Ltd",

number = "6",

}

TY - JOUR

T1 - Dietary recommendations for type 2 diabetes patients

T2 - Lessons from recent clinical and basic research in Asia

AU - Seino, Yusuke

AU - Ueno, Shinji

AU - Yabe, Daisuke

AU - Suzuki, Atsushi

N1 - Funding Information: YS received a scholarship grant from Grants‐in‐Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd. Funding Information: YS received a scholarship grant from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd.

PY - 2019/11/1

Y1 - 2019/11/1

UR - http://www.scopus.com/inward/record.url?scp=85074392698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074392698&partnerID=8YFLogxK

U2 - 10.1111/jdi.13135

DO - 10.1111/jdi.13135

M3 - Article

C2 - 31472101

AN - SCOPUS:85074392698

VL - 10

SP - 1405

EP - 1407

JO - Journal of Diabetes Investigation

JF - Journal of Diabetes Investigation

SN - 2040-1116

IS - 6

ER -